Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
P55201
UPID:
BRPF1_HUMAN
Alternative names:
Bromodomain and PHD finger-containing protein 1; Protein Br140
Alternative UPACC:
P55201; B4DEZ6; Q7Z6E0; Q8TCM6; Q9UHI0
Background:
Peregrin, also known as Bromodomain and PHD finger-containing protein 1, plays a pivotal role in chromatin remodeling through its involvement in various histone acetyltransferase (HAT) complexes. These complexes, including MOZ/MORF and HBO1, are crucial for histone H3 acetylation, specifically at 'Lys-14' and 'Lys-23', facilitating transcriptional activation of key genes such as RUNX1 and RUNX2.
Therapeutic significance:
Peregrin's association with Intellectual developmental disorder with dysmorphic facies and ptosis highlights its potential as a therapeutic target. Understanding the role of Peregrin could open doors to potential therapeutic strategies for treating neurodevelopmental disorders.